Dear Colleagues,
The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies (IMPT), and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available.
If you have a resource to include in our next issue, please send to Vanetta Thomas at [email protected]. Previous issues are available on the CAMI Health website.
Best,
IMPT Secretariat Staff
|
|
Just Released
We are excited to share the following Health Affairs Blog co-authored by IMPT Director Bethany Young Holt and key IMPT member Helen Rees:
|
Upcoming Events
IMPT members will be presenting at several upcoming events. We encourage you to attend their sessions if you plan to attend the following conferences:
|
Journal Articles
Disclosure of pharmacokinetic drug results to understand nonadherence. Van der Straten, A., Montgomery, E.T., Musara, P., Etima, J., Naidoo, S., ...Mensch, B. (2015, October 23). AIDS, 29(16), 2161-2171. HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions. Rubens, M., Ramamoorthy, V., Saxena, A., Shehadeh, N., and Appunni, S. (2015). Journal of Immunology Research. HIV Worldwide 1990-2013. Leach-Kemon, K., Shepard, D., O'Rourke, K., VanderZanden, A. (2015, October 20). The Journal of the American Medical Association, 314(15). Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection. Masson, L., Arnold, K.B., Little, F., Mlisana, K., Lewis, D.A., Mkhize, N., ...Passmore, J.S. (2015, October 28). Sexually Transmitted Infections. Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial. Chen, B., Panther, L., Marzinke, M.A., Hendrix, C.W., Hoesley, C.J., van der Straten, A., ...Dezzutti, C.S. (2015, November 1). Journal of Acquired Immune Deficiency Syndromes, 70(3), 242-249. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. Patel, R.C., Onono, M., Gandhi, M., Blat, C., Hagey, J., Shade, S.B., ...Cohen, C. (2015, October 15). The Lancet HIV, 2(11), e474-e482. Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers. Coll, J., Molt�, J., Boix, J., G�mez-Mora, E., Else, L., Garc�a, E., ...Cabrera, C. (2015, October 23). AIDS, 29(16), 2149-21547.
|
|
|
|
|